Core Viewpoint - CNO Financial Group, Inc. reported mixed first-quarter 2025 results, with increased insurance policy income driven by higher collected premiums, but offset by lower investment results and fee revenues [1][2]. Financial Performance - Adjusted earnings per share (EPS) for Q1 2025 were 79 cents, matching the Zacks Consensus Estimate, and reflecting a year-over-year increase of 51.9% [2]. - Operating revenues decreased by 12.6% year over year to $1 billion, although it exceeded the consensus estimate by 5.2% [2]. - Total insurance policy income rose to $650.7 million from $628.4 million in the prior year, but fell short of the Zacks Consensus Estimate of $651.4 million [3]. Investment Income and Expenses - Net investment income dropped to $311.5 million from $469.2 million year over year [4]. - Total benefits and expenses decreased by 2.4% year over year to $986.4 million, attributed to lower insurance policy benefits and operating costs [6]. Premiums and Collected Income - Total collected premiums increased by 5.5% year over year to $1.1 billion, with annuity premiums at $442 million (up 12%), health premiums at $405.7 million (up 0.2%), and life premiums at $244.4 million (up 3%) [5]. - New annualized premiums for health products rose by 8.8%, while life products saw a decline of 5.3% [6]. Financial Position - As of March 31, 2025, unrestricted cash and cash equivalents were $928.2 million, down from $1.7 billion at the end of 2024 [7]. - Total assets decreased to $37.4 billion from $37.9 billion at the end of 2024, while total shareholders' equity improved by 1.3% to $2.5 billion [7]. - Book value per common share increased by 3% to $25.33, and operating return on equity improved by 340 basis points year over year to 11.9% [8]. Shareholder Returns - CNO Financial returned $99.9 million to shareholders through share buybacks and $16.9 million in dividends during the first quarter [9]. - The company has a remaining repurchase capacity of $640.4 million as of March 31, 2025 [9]. Guidance - CNO Financial reaffirmed its 2025 guidance, projecting operating EPS in the range of $3.70-$3.90 and excess cash flow between $200-$250 million [10]. - The company estimates an expense ratio of 19-19.4% and an effective tax rate around 23% for 2025 [10].

Core Viewpoint - CNO Financial Group, Inc. has announced a $0.01 increase in its quarterly dividend, marking the thirteenth consecutive annual increase, reflecting the company's commitment to returning value to shareholders [1]. Group 1: Dividend Announcement - The Board of Directors declared a quarterly cash dividend of $0.17 per share on the company's common shares [1]. - The dividend will be payable on June 24, 2025, to shareholders of record at the close of business on June 10, 2025 [1]. Group 2: Company Overview - CNO Financial Group, Inc. focuses on securing the future of middle-income America by providing life and health insurance, annuities, financial services, and workforce benefits solutions [2]. - The company operates through various brands, including Bankers Life, Colonial Penn, Optavise, and Washington National [2]. - CNO manages 3.2 million policies and has total assets amounting to $37.4 billion [2]. - The company employs 3,400 associates, 4,800 exclusive agents, and over 5,500 independent partner agents to assist customers with financial decisions [2].

Financial Data and Key Metrics Changes - Operating earnings per diluted share were $0.79, up 52%, and $0.74, up 42%, excluding significant items [5][25] - Book value per diluted share, excluding AOCI, was $37.03, up 6% [7] - Operating return on equity excluding significant items was 11.9% on a trailing twelve-month basis [26] Business Line Data and Key Metrics Changes - Consumer division saw annuity collected premiums up 12%, account values up 7%, and premium per policy up 19% [10] - Health NAP was up 9%, with Medicare Supplement NAP up 24% and Medicare Advantage policies up 42% [13][14] - Worksite insurance sales were up 11%, with critical illness insurance up 37% and life insurance up 17% [19] Market Data and Key Metrics Changes - New money rates exceeded 6% for nine consecutive quarters, with a new money rate of 6.43% [6][28] - Total investment income was up 16% for the quarter, marking the sixth consecutive quarter of growth [29] Company Strategy and Development Direction - The company aims to leverage its business model for sustained profitable growth and drive ROE expansion [8][32] - Focus on reaching the underserved middle-income market through a combination of virtual connections and local agents [9] Management's Comments on Operating Environment and Future Outlook - Management acknowledged deteriorating visibility into macroeconomic drivers but expressed confidence in navigating volatility [7][34] - The company reaffirmed its full-year guidance for 2025, despite acknowledging increased risks due to market volatility [31][32] Other Important Information - The company returned $117 million to shareholders, maintaining strong capital and liquidity levels [6] - A new product, Optimize Clear, was introduced to enhance service offerings [23] Q&A Session Summary Question: On buybacks and macro environment - Management indicated a willingness to continue share buybacks, with $100 million deployed in the first quarter [37] Question: Fee revenue and GAAP accounting - Management explained the impact of ASC 606 on revenue recognition, noting potential future reversals [40][41] Question: Outlook for direct-to-consumer life sales - Management expressed optimism for a bounce back in sales, while acknowledging shifts in advertising strategies [58] Question: Medicare business and potential shifts - Management noted strong growth in Medicare Advantage policies and indicated a potential shift back to Medicare Supplement could be beneficial [72][74] Question: Geographic expansion in worksite - Management confirmed ongoing geographic expansion efforts and expected continued growth from new regions [82]

Financial Data and Key Metrics Changes - Operating earnings per diluted share were $0.79, up 52%, and $0.74, up 42% excluding significant items [5][24] - Book value per diluted share, excluding AOCI, was $37.03, up 6% [7] - Capital and liquidity remain well above target levels after returning $117 million to shareholders [6] Business Line Data and Key Metrics Changes - Consumer division saw annuity collected premiums up 12%, account values up 7%, and premium per policy up 19% [10] - Health NAP was up 9%, with Medicare Supplement NAP up 24% and Medicare Advantage policies up 42% [13][14] - Worksite insurance sales were up 11%, with critical illness insurance up 37% and life insurance up 17% [19] Market Data and Key Metrics Changes - New money rates exceeded 6% for nine consecutive quarters [6] - Total investment income was up 16% for the quarter, marking the sixth consecutive quarter of growth [28] - The market value of invested assets grew 11% in the quarter [29] Company Strategy and Development Direction - The company aims to leverage its business model for sustained profitable growth and drive ROE expansion [8] - Focus on reaching the underserved middle-income market remains a key differentiator [9] - Introduction of new products like Optimize Clear to enhance service offerings [22] Management's Comments on Operating Environment and Future Outlook - Management acknowledges deteriorating visibility into macroeconomic drivers but expresses confidence in navigating volatility [7][31] - The company reaffirms its full-year guidance despite a more volatile environment [30] - Long-term commitment to improving run rate ROE by 150 basis points from 2025 to 2027 [31] Other Important Information - The company plans to launch a new series of investor briefings starting in June [34] - Fee income was adversely impacted by ASC 606 revenue recognition accounting [24] Q&A Session Summary Question: On buybacks, will the company lean into buybacks in the current macro environment? - Management indicated a willingness to continue elevated buyback levels due to strong cash flow [37] Question: Can you explain the GAAP accounting revenue recognition for Medicare Advantage? - Management provided details on how revenue recognition differs from cash flow, emphasizing the impact of sales mix on fee income [39][40] Question: What is the outlook for PAC in the Consumer division? - Management expects continued growth in PAC, despite potential quarter-to-quarter fluctuations [66] Question: How does the company view the demand for insurance products in a recession? - Management believes demand for products will remain strong due to demographic trends, despite potential economic downturns [70][71] Question: What are the implications of potential shifts from Medicare Advantage to Medicare Supplement? - Management expressed confidence that any shifts would not materially impact the business, as they can benefit from both product lines [76] Question: Can you elaborate on the geographic expansion in the worksite division? - Management confirmed ongoing disciplined geographic expansion contributing to sales growth [85]

First Quarter 2025 Financial and operating results for the period ended March 31, 2025 April 28, 2025 Unless otherwise specified, comparisons in this presentation are between 1Q24 and 1Q25. 1 IMPORTANT LEGAL INFORMATION Forward-Looking Statements OUR PURPOSE We secure the future of middle-income America. OUR MISSION Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about fu ...

Core Insights - CNO Financial reported a revenue of $1.01 billion for Q1 2025, reflecting a year-over-year decline of 12.6% while EPS increased to $0.79 from $0.52 a year ago, exceeding the Zacks Consensus Estimate of $961.36 million by 5.15% [1] Group 1: Financial Performance - The reported insurance policy income was $650.70 million, slightly below the average estimate of $651.36 million, marking a year-over-year increase of 3.6% [4] - The Insurance Product Margin for Annuity was reported at $54.50 million, lower than the estimated $60.39 million [4] - The Insurance Product Margin for Life was $68.20 million, surpassing the average estimate of $52.37 million [4] - The Insurance Product Margin for Health was $126.20 million, slightly below the average estimate of $127.96 million [4] Group 2: Stock Performance - CNO shares have returned -4.6% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Group 1: Earnings Performance - CNO Financial reported quarterly earnings of $0.79 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.52 per share a year ago [1] - The company had a surprise in the previous quarter, posting earnings of $1.31 per share against an expected $1.07, resulting in a surprise of 22.43% [1] - Over the last four quarters, CNO has exceeded consensus EPS estimates three times [1] Group 2: Revenue Performance - CNO posted revenues of $1.01 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.15%, but down from $1.16 billion year-over-year [2] - The company has topped consensus revenue estimates four times over the last four quarters [2] Group 3: Stock Performance and Outlook - CNO shares have increased by approximately 6.4% since the beginning of the year, contrasting with the S&P 500's decline of -6.1% [3] - The future stock price movement will largely depend on management's commentary during the earnings call [3] - The current consensus EPS estimate for the upcoming quarter is $0.91 on revenues of $942.33 million, and for the current fiscal year, it is $3.82 on revenues of $3.88 billion [7] Group 4: Industry Context - The Zacks Industry Rank for Insurance - Multi line is currently in the top 20% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8]

Financial Performance - Total revenues for Q1 2025 were $1,004.1 million, a decrease of 13.1% compared to $1,156.5 million in Q1 2024[7] - Net income for Q1 2025 was $13.7 million, significantly lower than $112.3 million in Q1 2024, reflecting a decline of 87.8%[7] - The company reported a total investment income of $375.1 million for Q1 2025, compared to $301.9 million in Q1 2024, marking an increase of 24.2%[7] - Net operating income for 2024 YTD was $429.3 million, with Q4 2024 at $138.0 million[11] - Net income for 2024 YTD reached $404.0 million, with Q4 2024 reporting $166.1 million[9] - Net income for Q4 2024 reached $141.4 million, contributing to a total net income of $176.6 million for the year 2024[28] Assets and Liabilities - Total assets as of March 2025 were $37,436.3 million, a slight decrease from $37,852.6 million in December 2024[5] - Total liabilities decreased to $34,905.8 million in March 2025 from $35,354.2 million in December 2024, a reduction of 1.3%[5] - Policyholder account balances reached $17,346.0 million in March 2025, compared to $17,615.8 million in December 2024, indicating a decline of 1.5%[5] - Future policy benefits liability was reported at $11,773.0 million in March 2025, slightly up from $11,705.5 million in December 2024[5] Insurance Product Performance - Insurance policy income increased to $650.7 million in Q1 2025, up from $628.4 million in Q1 2024, representing a growth of 3.7%[7] - Total insurance product margin for 2024 YTD reached $1,040.0 million, with a quarterly margin of $253.1 million in Q4 2024[9] - Annuity margin for 2024 YTD was $274.2 million, with Q4 2024 showing a margin of $55.0 million[11] - Health margin for 2024 YTD totaled $516.8 million, with Q4 2024 at $130.1 million[11] - Life margin for 2024 YTD was $249.0 million, with Q4 2024 reporting $68.0 million[11] Premiums and Collections - Total collected premiums for 2024 reached $4,378.7 million, with Q4 alone contributing $1,152.5 million, reflecting a steady growth trend[19] - Annuity products collected premiums totaled $1,790.6 million YTD, with fixed indexed annuities showing a quarterly increase from $345.5 million in Q1 to $409.9 million in Q4[19] - Health products collected premiums amounted to $1,627.6 million YTD, with supplemental health premiums remaining stable around $181.4 million to $183.2 million across the quarters[19] - Life products collected premiums totaled $960.5 million YTD, with traditional life premiums consistently around $176.8 million to $181.1 million throughout the quarters[19] Investment Income - Net investment income for Q1 2024 was $469.2 million, with a total of $1,748.8 million year-to-date[31] - Total investment income allocated to health products was $75.1 million in Q1 2025, consistent with Q4 2024[41] - Total investment income allocated to life products was $37.6 million in Q1 2025, compared to $36.5 million in Q1 2024[41] - Investment income not allocated to product lines was $38.0 million in Q1 2025, down from $65.3 million in Q4 2024[41] Future Outlook - The company anticipates continued focus on expanding its insurance product offerings and enhancing customer engagement strategies in the upcoming quarters[6] - The company is focusing on expanding its market presence and enhancing product offerings to drive future growth[20] - The company expects continued growth in annuity issuances, projecting a strong performance in the upcoming quarters[25]

Core Insights - CNO Financial Group reported a net income of $13.7 million, or $0.13 per diluted share, for Q1 2025, a significant decrease from $112.3 million, or $1.01 per diluted share, in Q1 2024. The decline was attributed to non-economic accounting impacts from market volatility [1][6] - The company's net operating income for Q1 2025 was $81.1 million, or $0.79 per diluted share, representing a 41% increase from $57.5 million, or $0.52 per diluted share, in Q1 2024. Significant items positively impacted both net income and net operating income by $5.3 million, or $0.05 per diluted share, in Q1 2025 [1][5][12] Financial Summary - Total revenues for Q1 2025 were $1,004.1 million, down from $1,156.5 million in Q1 2024. Insurance policy income increased to $650.7 million from $628.4 million, while net investment income from general account assets rose to $375.1 million from $301.9 million [28][29] - The company returned $116.8 million to shareholders, with a book value per share of $25.33, up 6% from the previous year. The return on equity (ROE) was reported at 12.1%, with an operating ROE of 12.6% [5][19][21] Operational Highlights - CNO's annuity collected premiums increased by 12%, and client assets in brokerage and advisory services rose by 16%. The Consumer Division's new annualized premiums (NAP) grew by 9%, with Medicare Supplement NAP up 24% [5] - The Worksite Division's NAP increased by 11%, and the producing agent count rose by 8%, indicating strong operational performance across key business segments [5] Investment Portfolio - As of March 31, 2025, CNO's fixed maturity portfolio had a fair value of $23.3 billion, with net unrealized losses of $2.3 billion. The allowance for credit losses was $38.9 million [15][18] - The consolidated statutory risk-based capital ratio for U.S.-based insurance subsidiaries was estimated at 379% as of March 31, 2025, reflecting strong capital management [16] Shareholder Information - The company repurchased $99.9 million of common stock during Q1 2025, with an average cost of $40.24 per share. As of March 31, 2025, CNO had 99.9 million shares outstanding and authority to repurchase an additional $640.4 million of common stock [17][19]

Core Viewpoint - CNO Financial is expected to report a significant increase in quarterly earnings per share, while revenues are projected to decline year-over-year [1]. Earnings Estimates - Analysts predict CNO will post quarterly earnings of $0.79 per share, reflecting a 51.9% increase compared to the same period last year [1]. - The consensus EPS estimate has been revised downward by 0.4% over the past 30 days, indicating a collective reassessment by analysts [2]. Revenue Projections - Revenues for CNO are forecasted to be $961.36 million, representing a year-over-year decrease of 16.9% [1]. Key Metrics Insights - 'Insurance policy income' is projected to reach $651.36 million, indicating a 3.7% increase from the prior-year quarter [5]. - The average estimate for 'Insurance Product Margin- Annuity' is $60.39 million, up from $52 million reported in the same quarter last year [5]. - The consensus estimate for 'Insurance Product Margin- Life' stands at $52.37 million, down from the year-ago figure of $54.60 million [5]. - Analysts estimate 'Insurance Product Margin- Health' will reach $127.96 million, compared to $123 million from the previous year [6]. Stock Performance - CNO shares have experienced a decline of 8.6% in the past month, contrasting with a 6.6% decline in the Zacks S&P 500 composite [6]. - CNO holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6].